Post by SCARLETRED Holding GmbH

🎗️ May is about #SkinCancerAwareness  🔊 🔬 Skin cancer is one of the most common cancer groups in modern civilization - and one of the most preventable. Prevention requires more than sunscreen: It demands verified clinical information, objective documentation, and consistent monitoring over time. 📌 A few facts:  In Europe, 7.3 million people are affected - with incidence projected to rise by 34% by 2040.  In the U.S., 1 in 5 Americans is likely to develop skin cancer by age 70.  In Australia and New Zealand, 2 in 3 are likely to be diagnosed in their lifetime. 🔎 Early detection changes outcomes. That is why Scarletred®Vision enables objective, AI-powered skin lesion documentation, quantification, and longitudinal monitoring. Emerging research goes even further: A monocentric study at the Hospital of Wiener Neustadt is currently investigating whether iris pigmentation may be a predictor for basal cell carcinoma risk - using Scarletred®Vision, powered by #ARORA®AI. 🔗 Read more in our article:  https://lnkd.in/esuKJk7V 👇🏼 Swipe through our gallery to find out more! SCARLETRED Holding GmbH | SCARLETRED Inc | Scarletred®Vision #SkinCancer #Dermatology #DigitalHealth #MedicalDevice #SkinHealth #Prevention #ScarletredVision #ARORA®AI #EarlyDetection